Literature DB >> 10980141

Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.

E C Holland1, Y Li, J Celestino, C Dai, L Schaefer, R A Sawaya, G N Fuller.   

Abstract

The cells of origin for oligodendrogliomas and astrocytomas are not known but are presumed to be oligodendrocyte and astrocyte precursors, respectively. In this paper we report the generation of mixed gliomas from in vivo transformation of glial fibrillary acidic protein (GFAP)-positive cells (differentiated astrocytes) with polyoma virus middle T antigen (MTA). MTA is a powerful oncogene that activates a number of signal transduction pathways, including those proposed to be involved in gliomagenesis, and has been shown to induce tumors in many cell types. We have achieved transfer of MTA expression specifically to GFAP(+) cells in vivo using somatic cell gene transfer, and find resultant formation of anaplastic gliomas with mixed astrocytoma and oligodendroglioma morphological features. We conclude that GFAP- expressing astrocytes, with appropriate signaling abnormalities, can serve as the cell of origin for oligodendrogliomas, astrocytomas, or mixed gliomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980141      PMCID: PMC1885688          DOI: 10.1016/S0002-9440(10)64615-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene.

Authors:  V L Bautch; S Toda; J A Hassell; D Hanahan
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

2.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen.

Authors:  A Aguzzi; E F Wagner; R L Williams; S A Courtneidge
Journal:  New Biol       Date:  1990-06

4.  A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family.

Authors:  M Rassoulzadegan; S A Courtneidge; R Loubière; P el Baze; F Cuzin
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

5.  Tumour induction in fetal brain transplants exposed to the viral oncogenes polyoma middle T and v-src.

Authors:  O D Wiestler; A Aguzzi; R L Williams; E F Wagner; C A Boulter; P Kleihues
Journal:  IARC Sci Publ       Date:  1989

6.  A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor.

Authors:  P Bates; J A Young; H E Varmus
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

7.  Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.

Authors:  S M Dilworth; C E Brewster; M D Jones; L Lanfrancone; G Pelicci; P G Pelicci
Journal:  Nature       Date:  1994-01-06       Impact factor: 49.962

8.  The polyomavirus early region gene in transgenic mice causes vascular and bone tumors.

Authors:  R Wang; V L Bautch
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.

Authors:  K R Auger; C L Carpenter; S E Shoelson; H Piwnica-Worms; L C Cantley
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

10.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

View more
  31 in total

Review 1.  Glioma classification: a molecular reappraisal.

Authors:  D N Louis; E C Holland; J G Cairncross
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Authors:  Wen Bu; Zhenyu Liu; Weiyu Jiang; Chandandeep Nagi; Shixia Huang; Dean P Edwards; Eunji Jo; Qianxing Mo; Chad J Creighton; Susan G Hilsenbeck; Andrew D Leavitt; Michael T Lewis; Stephen T C Wong; Yi Li
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

3.  The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo.

Authors:  Jay P Reddy; Yi Li
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-11-24       Impact factor: 2.673

Review 4.  Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors.

Authors:  L Uhrbom; E C Holland
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 5.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 6.  Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Brain Pathol       Date:  2011-07-07       Impact factor: 6.508

Review 7.  Animal models of cell cycle dysregulation and the pathogenesis of gliomas.

Authors:  E C Holland
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

8.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 9.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

10.  Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.

Authors:  Wolf Mueller; Christian Hartmann; Annegret Hoffmann; Wolfgang Lanksch; Jürgen Kiwit; Jörg Tonn; Julian Veelken; Johannes Schramm; Michael Weller; Otmar D Wiestler; David N Louis; Andreas von Deimling
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.